R-Zero engaged an independent clinical testing lab to validate the efficacy of its UR-UVGI disinfection device, Beam, against human coronavirus, MRSA, and Klebsiella aerogenes. R-Zero selected microorganisms endemic to the environments Beam will be used in, ensuring partners understand Beam’s efficacy against microorganisms most important to them. The following represents the results of that testing.
The R-Zero Beam is extremely adept at inactivating viable bioaerosols from room air. Within 45 min of operation, the R-Zero Beam had removed approximately 6.0 net log (99.9999%) of bioaerosols from the test chamber for all of the organisms. Based on the viability reduction seen with the various microorganisms tested, tentative conclusions can be made about how the device would inactivate more lethal viruses and bacteria with similar properties to the tested surrogates. The clean air delivery rate was calculated for all organisms, the device had an average CADR of 796.96 CFM
Species |
# of Trials |
Trial Time |
Data Type |
Trial 1 |
Trial 2 |
Trial 3 |
Staphylococcus epidermidis |
3 |
60 |
Net Log Reduction |
8.06 |
7.19 |
7.47 |
Net % Reduction |
99.9999991% |
99.9999936% |
99.9999966% |
|||
Klebsiella aerogenes |
3 |
60 |
Net Log Reduction |
4.98 |
5.53 |
5.45 |
Net % Reduction |
99.9989429% |
99.9997019% |
99.9996439% |
|||
T1 Bacteriophage |
3 |
60 |
Net Log Reduction |
5.60 |
6.03 |
6.21 |
Net % Reduction |
99.9997515% |
99.9999077% |
99.9999385% |
|||
SARS-CoV-2 |
3 |
30 |
Net Log Reduction |
4.0 |
4.0 |
4.0 |
Net % Reduction |
99.997% |
99.997% |
99.997% |
Link to Third Party Lab Testing